Assenagon Asset Management S.A. Axsome Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $54.8 Billion
- Q1 2025
A detailed history of Assenagon Asset Management S.A. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 627,418 shares of AXSM stock, worth $63.2 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
627,418
Previous 3,701
16852.66%
Holding current value
$63.2 Million
Previous $313,000
23278.59%
% of portfolio
0.13%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AXSM
# of Institutions
409Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$390 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$332 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$294 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$170 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$98.3 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.32B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...